JP Patent

JP2017500281A — ２’−デオキシ−２’，２’−ジフルオロテトラヒドロウリジンへの合成経路

Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2017-01-05 · 9y expired

What this patent protects

本発明は、２’−デオキシ−２’，２’−ジフルオロテトラヒドロウリジン化合物を合成する方法及び中間体に関する。

USPTO Abstract

本発明は、２’−デオキシ−２’，２’−ジフルオロテトラヒドロウリジン化合物を合成する方法及び中間体に関する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2017500281A
Jurisdiction
JP
Classification
—
Expires
2017-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.